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Abstract 
The colon is a very rare metastatic localization. Here we report a case of colonic 
metastases from gastric adenocarcinoma whose clinical presentation was suggestive of a 
de novo adenocarcinoma of the ascending colon. The authors discuss that in the 
presence of a previous history of gastric cancer, immunohistochemical analysis on 
endoscopic biopsies may help in the definition of a differential diagnosis. Furthermore, 
this rare metastatic localization might suggest a poor prognosis and a more accurate 
diagnostic work-up. 
 
Introduction 
Gastric carcinoma is the second cause of cancer death worldwide. Advanced stages of 
the disease may result in both synchronous and metachronous metastases. However, 
colonic metastases from gastric cancer are very rare. We describe a case of a signet ring 
cell carcinoma of the stomach metastasizing to the ascending colon (fig. 1). 
Case Report 
In March 2008, a 77-year-old man followed up in our institution for gastric cancer was found to 
have an ascending colonic adenocarcinoma. Clinical history was positive for prostate acinar 
adenocarcinoma treated with radical prostatectomy in 2003 (pT2pN0, G2, Gleason 2 + 3, CK34–, BE12–
) and chronic symptomatic nephrolithiasis. In January 2007, the patient had been first diagnosed with a 
gastric adenocarcinoma in our institution after presenting common symptoms including gastric 
bleeding and weight loss. At that time a routine work-up was performed including  
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esophagogastroduodenoscopy (EGDS) with biopsies and contrast CT scanning of the chest and 
abdomen. Imaging and pathology findings demonstrated the presence of an adenocarcinoma of the 
angulus. Notably, the preoperative CT scan showed small, multiple bilateral lung micronodules 
(maximum diameter 0.7 cm) deserving strict follow-up. Preoperative laboratory findings included 
anaemia, resulting from bleeding (Hb 9,4 g/dl), and CEA and Ca19-9 levels within the range. On 
January 26, the patient underwent subtotal gastrectomy and D2 lymphadenectomy. Macroscopic 
pathology examination reported the presence of 2 different ulcerated lesions of 2.5 and 1.0 cm in the 
longest diameter, respectively. The larger lesion infiltrated the entire wall to the serosa, while the smaller 
one infiltrated the submucosa. Final pathology identified an undifferentiated mixed adenocarcinoma 
with signet ring and intestinal differentiation, and a moderately differentiated adenocarcinoma of 
intestinal type, respectively. All margins were clear. Twenty-eight lymph nodes were isolated and 12 
were found involved by metastatic dissemination. The stage was pT2b(m) pN2 (12/28) Mx (stage IIIA 
according to TNM, AJCC, ed. 6). Intraperitoneal cytology results were negative. 
The patient received an adjuvant chemotherapy with fluorouracil plus folinic acid according to de 
Gramont regimen from March to September. During chemotherapy, the Ca19-9 levels were 74 IU/ml 
and a CT showed stable lung nodules and no evidence of local or metastatic disease relapse. 
Just after the end of chemotherapy the patient presented at the follow-up visit with altered touch 
sensation of the right hand, recently occurring diplopia, a Ca19-9 of 111 IU/ml and a new CT-detected 
sub-centimetrical nodule of the left lung with no subsequent dimensional increase at follow-up. The 
patient was examined by a neurologist who diagnosed a mononeuropathy of the VI right cranial nerve; 
a brain MRI showed vascular encephalopathy. Later the patient developed pain to the left calf and thigh, 
foot neuropathy (tingling) and imbalance while walking with overall worsening of his performance 
status. A FDG-PET scan was performed showing a single area of pathological uptake to the ascending 
colon. This finding was confirmed by a colonoscopy demonstrating the presence of a neoplastic lesion 
typified as a poorly differentiated adenocarcinoma at pathology examination of biopsies. The Ca19-9 
rose to 229 IU/ml. 
Then the patient was referred to the division of general and laparoscopic surgery, and he underwent 
a right hemicolectomy with loco-regional node excision. The pathological examination demonstrated 
multiple mucosal and intramucosal localizations of poorly differentiated carcinoma with signet ring cell 
differentiation. Two out of 3 analyzed lymph nodes were metastatic. Immunohistochemistry showed 
positivity for cytokeratin 7 (CK7), and negativity for cytokeratin 20 (CK20), CDX-2 and CDX-3 (fig. 2). 
One month later, the clinical picture was rapidly complicated with the worsening of neurological 
symptoms including facial nerve deficit, with right hypoacusis and swallowing disturbances and leg 
pain. Brain MRI showed progressing disease with complete obliteration of the right and part of the left 
Meckel’s cavity, involvement of V facial nerve, and of the internal auditory conduct. A FDG-PET scan 
was positive on the right presacral lesion. Gamma knife and local radiotherapy were collegially 
discussed but not performed due to the poor performance status, and the patient was sent to best 
supportive care. 
Discussion 
Metastases rarely involve the intestinal tract; however, post-mortem studies suggest a 
much higher incidence [1–5]. As a matter of fact, gut metastases have been extensively 
described for specific tumors such as melanoma, breast or lung cancer, and contiguous 
spreading of ovarian carcinomas [6–8]. 
Intestinal metastases from gastric adenocarcinoma have been rarely reported [9–10]. 
Generally this unusual localization has been associated to Lauren’s diffuse type histology, 
linitis plastica and peritoneal dissemination [5, 11]. In a retrospective radiological analysis 
of 23 cases of colorectal gastric cancer metastases, Jang et al. [5] found that primary 
tumors showed poorly differentiated adenocarcinoma with signet ring features in 7 cases 
(30.4%) and signet ring adenocarcinoma in 5 more cases (22%). Consistently among these 
cases, 9 (75%) showed linitis plastica. However, neither linitis plastica nor macroscopic 
peritoneal seeding was present in our patient at the time of the removal of the primary 
tumor and colorectal metastasis, respectively. When CT or different imaging techniques  
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such as PET scan show the presence of a colorectal neoplasia in a patient with positive 
clinical history for gastric cancer, a colonoscopy-guided biopsy should be considered, 
keeping in mind the possibility of a false negative result because of inadequate sampling 
in up to 54% [5]. A possible explanation may be that metastatic carcinoma usually 
preserves the mucosa, and the positive yield from endoscopic biopsy is low. Even with a 
deep biopsy specimen, the sparseness of tumor cells within the exuberant fibrosis may 
hinder the detection of linitis plastica [5]. In our case the diagnosis of a poorly 
differentiated adenocarcinoma suggested a primary colorectal cancer. CDX-2 and CDX-3 
negativity suggested a non-colorectal origin of the tumor, confirmed by the negative 
CK20 staining [12]. In order to exclude a localization from prostate cancer, CK7 staining 
(which was positive) and an accurate revision of slides form the primary tumors were 
performed by the pathologist. These findings suggest that immunohistochemical profiling 
might prove useful in selected cases when a differential diagnosis must be assessed also on 
bioptic material. Nonetheless, gastric adenocarcinoma, especially if it is poorly 
differentiated or the signet ring cell type, should be considered as one of the common 
tumors that have the propensity for rare intestinal metastases. 
 
 
 
 
 
Fig. 1. Right colon localization of gastric carcinoma. (Patient’s surgical specimen). HE. ×40. 
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Fig. 2. Right colon localization of gastric carcinoma. (Patient’s surgical specimen). Neoplastic tissue in 
the context of normal mucosa shows negative CDX-2 (a), CDX-3 (b), cytokeratin 20 (c), and positive 
cytokeratin 7 (d). a ×20; b–d ×40. 
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